Anthelmintic Drugs Market: Steady Growth Driven by Rising Parasitic Infections to Reach $3.7 Billion by 2031 | TMR Analysis

The Anthelmintic Drugs Market is a crucial segment within the pharmaceutical industry, driven by the increasing prevalence of parasitic infections in humans and animals. Anthelmintic drugs are used to treat infections caused by parasitic worms, including roundworms, tapeworms, and flukes. With the growing burden of parasitic diseases, rising awareness about deworming, and advancements in drug formulations, the market is poised for steady growth.

Get Sample PDF Brochure from here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=50688

Market Overview

The global anthelmintic drugs market was valued at $2.6 billion in 2022 and is projected to grow at a CAGR of 3.9%, reaching $3.7 billion by 2031. This growth is driven by the rising prevalence of parasitic infections, increasing demand for veterinary anthelmintics, and growing awareness about the importance of deworming.

Top Manufacturers:

Novartis AG
Zoetis, Inc.
Amneal Pharmaceuticals, Inc.
Cipla Inc.
Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
Sun Pharmaceutical Industries Ltd.
GlaxoSmithKline plc
Bayer AG
Merck & Co. Inc. (Intervet Inc.)
Boehringer Ingelheim International GmbH

Key Growth Drivers

1. Rising Prevalence of Parasitic Infections

The increasing incidence of parasitic infections, particularly in developing regions, is driving the demand for anthelmintic drugs.

2. Growing Livestock Industry

The expansion of the livestock industry, driven by rising demand for animal-derived products, is boosting the need for effective parasitic control measures.

3. Increasing Awareness About Deworming

Growing awareness about the importance of deworming in humans and animals is driving the adoption of anthelmintic drugs.

4. Advancements in Drug Formulations

Innovations in drug formulations, such as extended-release and combination therapies, are enhancing the efficacy and safety of anthelmintic drugs.

Challenges

1. Resistance to Anthelmintic Drugs

The emergence of drug-resistant parasites poses a challenge to the effectiveness of anthelmintic drugs.

2. High Costs of Advanced Formulations

The costs associated with advanced drug formulations can limit accessibility, particularly in low-income regions.

3. Regulatory Hurdles

Stringent regulations for drug approvals can delay market entry and increase development costs.

Recent Trends and Developments

1. Launch of Combination Therapies

Company: Zoetis
Zoetis introduced combination anthelmintic therapies for livestock, offering improved efficacy and convenience.

2. Expansion in Emerging Markets

Company: Bayer
Bayer expanded its distribution network for anthelmintic drugs in Asia-Pacific and Africa, increasing market penetration.

3. Focus on Pediatric Deworming

Organization: World Health Organization (WHO)
The WHO launched initiatives to promote pediatric deworming in endemic regions, boosting the demand for anthelmintic drugs.

4. Rising Adoption of Digital Tools

Company: Merck Animal Health
Merck integrated digital tools to track the efficacy of its anthelmintic products, improving customer engagement and outcomes.

Visit our report to discover essential insights and analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=50688

Future Outlook

The anthelmintic drugs market is expected to witness steady growth, driven by advancements in drug formulations, increasing awareness about deworming, and the rising prevalence of parasitic infections. Key opportunities include:

Development of cost-effective and easy-to-administer formulations.

Expansion into emerging markets with growing healthcare access.

Increased focus on combating drug resistance through innovative therapies.

Key Market Segments

Drug Class

Benzimidazole
Piperazine
Others

Route of Administration

Oral
Injectable

Application

Human
Parenchymal Neurocysticercosis
Gastrointestinal Infections
Animal

Target Pathogen

Ascaris Lumbricoides (Roundworm)
Trichuris Trichiura (Whipworm)
Enterobius Vermicularis (Pinworm)
Ancylostoma Duodenale (Hookworm)
Others

Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Veterinary Pharmacies
Veterinary Hospitals & Clinics

By Region

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Explore Latest Research Reports by Transparency Market Research:

Antiplatelet Drugs Market: https://www.globenewswire.com/news-release/2023/03/20/2630866/0/en/Antiplatelet-Drugs-Market-to-Hit-USD-4-1-Bn-by-2031-Due-to-the-Increase-in-Prevalence-of-Cardiovascular-Diseases-Latest-Study-by-TMR.html

Pharmaceutical Intermediates Market: https://www.globenewswire.com/news-release/2023/08/29/2733119/32656/en/Pharmaceutical-Intermediates-Market-Predicted-to-Reach-USD-53-4-billion-by-2031-Expanding-at-a-CAGR-of-6-Says-Transparency-Market-Research.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.